Meta-analysis assessing the cardiovascular efficacy of sodium-glucose co-transporter-2 inhibitors according to baseline treatment of interest
Patoulias D, Papadopoulos C, Katsimardou A, Doumas M
Am J Cardiol. Pb. online 15 October 2020
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Association of maternal prepregnancy diabetes and gestational diabetes mellitus with congenital anomalies of the newborn
Wu Y, Liu B, Sun Y, et al.
Diabetes Care. Pub. online 21 October 2020
Leggi
Effect of empagliflozin on the clinical stability of patients with heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial
Packer M, Anker SD, Butler J, et al.
Circulation. Pub. online 21 October 2020
Leggi
Depression and diabetes mellitus multimorbidity is associated with loss of independence and dementia poststroke
Ouk M, Wu CY, Colby-Milley J, et al.
Stroke. Pub. online 14 October 2020
Leggi
The impact of empagliflozin on obstructive sleep apnea, cardiovascular, and renal outcomes: an exploratory analysis of the EMPA-REG OUTCOME trial
Neeland IJ, Eliasson B, Kasai T et al.
Diabetes Care. 2020 Oct; dc201096.
Leggi
Antidiabetes agents and incident depression: a nationwide population-based study
Kessing LV, Rytgaard HC, Ekstrøm CT et al.
Diabetes Care. 2020 Sep; dc201561
Leggi
Effects of canagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease: a post-hoc analysis from the CREDENCE trial
Oshima M, Neuen BL, Jardine MJ, et al.
The Lancet Diabetes & Endocrinology. 2020, Nov; 8 (11):903-914
Leggi
Dietary pattern, colonic microbiota and immunometabolism interaction: new frontiers for diabetes mellitus and related disorders
Eslami M, Bahar A, Hemati M, et al.
Diabet Med. Pub. online 6 October 2020
Leggi
An early-onset subgroup of type 2 diabetes: a multigenerational, prospective analysis in the framingham heart study
Echouffo-Tcheugui JB, Niiranen TJ, McCabe EL, et al.
Diabetes Care. Pub. online 8 October 2020
Leggi
Updated meta-analysis assessing the effect of sodium-glucose co-transporter-2 inhibitors on surrogate endpoints in patients with heart failure with reduced ejection fraction
Patoulias D, Papadopoulos C, Kalogirou MS, et al.
The American Journal of Cardiology. Pub. online 10 October 2020
Leggi